Navigation Links
Next Inning Technology Research Identifies Winning Option Writing Strategies on Undervalued Stocks
Date:3/11/2009

PRINCETON, N.J., March 11 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), a subscription service focused on semiconductor and technology stocks, announced it has published a series of reports updating outlooks for Analog Devices (NYSE: ADI), Maxim Integrated Products (Nasdaq: MXIM), Pfizer (NYSE: PFE), DNP Select Income Fund (NYSE: DNP), and more.

Throughout this challenging period in the market, Editor Paul McWilliams has helped his subscribers identify uniquely positioned tech sector opportunities. These include a specialty semiconductor stock that has returned 64% since McWilliams added it to the Next Inning model portfolio late last year.

By taking a free test drive of Next Inning, you'll receive real-time notification of Next Inning model portfolio buy and sell orders, the seven Next Inning Paradigm Papers covering key, long-term tech trends, and the exclusive "2009 Guide to Undervalued Tech Stocks." These reports cover nearly 100 technology companies and are chock full of charts and ratings that identify potential big winners for 2009 and which stocks investors should avoid. To accept this offer, visit the following link:

https://www.nextinning.com/subscribe/index.php?refer=prn790

The Black-Scholes model doesn't take into account intrinsic value when valuing options, only volatility and time. In a high volatility environment, there is often an opportunity to "harvest" a premium by writing options in high quality stable companies with limited downside risk to intrinsic value. Next Inning has applied this approach to the technology sector in the past with success, has recently identified several new ideas, and will publish a several more taking advantage of these anomalies.

McWilliams also looks at these topics:

-- Why does McWilliams think the price of DNP is artificially depressed? Does he think the 12%+ dividend is safe?

-- How can investors lock in returns greater than 20% with Pfizer and, at the same time, drop their risk exposure below what it would be if they just held the stock?

-- What strategy can investors use to lock in a 28% return with a very low risk exposure in the Tech sector?

-- Why does McWilliams think Analog Devices is destined to beat its guidance this quarter? How can investors lock in a 41% total return with Analog Devices, yet expose themselves to less risk than a typical Analog Devices shareholder?

Founded in September 2002, Next Inning's model portfolio has returned 118% since its inception versus 5% for the Nasdaq.

About Next Inning:

Next Inning is a subscription financial newsletter focused on technology stocks. Editor Paul McWilliams is a 20+-year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin Next Inning Technology Research, +1-888-278-5515


'/>"/>
SOURCE Indie Research Advisors, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Olympic Gold Winning Supplement Lands in the US
2. Award Winning Photographer and Museum Founder to Donate Iconic Images In Support of the Innocence Project
3. Inspired Cancer Survivor Launches Customized Hair Replacement Techniques at Award-Winning Hair Salon
4. MidMichigan Health Cuts Out Trans Fats Beginning March 1
5. Disability Community Humble Beginnings Lead to Great Things at Disabled World
6. Governor Crist Proclaims Tobacco Free Florida Week Beginning February 27
7. Icagen Board Beginning to Follow Xmark Direction
8. A Newly Approved CMS Medicare Package Expands Reimbursement Coverage for Telehealth Originating Sites Beginning January 1, 2009
9. Pennsylvania to Offer Free Nicotine Replacement Therapy Kits Beginning Feb. 2
10. Author Shares Nine Resolutions for 2009 to Create a Winning Corporate Culture
11. Cadient Group Expands Award-Winning Capabilities with Key New Hires
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Mediaplanet is ... Wound Care" campaign in USA Today, which will educate readers on how to take ... the campaign, a large focus is placed on melanoma. Dancing with the Stars professional, ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... , ... May 26, 2017 , ... After raising nearly ... Top gadget will continue to be available at a discounted crowdfunding price on ... stress wherever they are, I also wanted to bring a fidget toy to the ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “When the Stars ... Home” is the creation of published author Laura Weigel Douglas, an avid reader who ... in a house that sometimes feels like Green Hills Adventure Camp. She couldn’t be ...
(Date:5/26/2017)... ... , ... Water damage to the flooring of several classrooms at The Fort ... with a number of critical issues to address before students could return to classes. ... little or no disruption to class schedules. Second, the project had to comply with ...
Breaking Medicine News(10 mins):
(Date:5/11/2017)... 11, 2017  Thornhill Research Inc. ( ... an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by ... Commercial Corporation (CCC) ( Ottawa, Ontario, Canada ... administer general anesthesia to patients requiring emergency medical ... US Marine Corps have been a longtime partner ...
(Date:5/10/2017)... , May 10, 2017 Radiology has become ... its costs have also spiraled to the number one ... to radiology than ever before as the most complete ... a patient with lower back pain an MRI may ... reason for pain, resulting in entirely different treatment protocols.  ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology: